Drug shortages during the study period may also have influenced treatment patterns
Because fertility may return unpredictably, providers should address contraceptive planning at treatment initiation
The Verdict: May offer supportive benefits for metabolism and satiety, but not a strong or direct GLP-1 booster
The most common side effects across all GLP-1 receptor agonists are nausea, vomiting, diarrhea, and constipation typically occurring during the dose escalation period and resolving within 48 weeks
In contrast, the observed response to adjuvant weight loss medication with phentermine, phentermine-topiramate extended release, lorcaserin, or naltrexone/bupropion was significantly better in gastric bypass and gastric banding patients compared with SG according to an observational study in 209 patients 1 year following BS
Semaglutide and tirzepatide are both injectable medications that aid in weight loss by regulating appetite and metabolism